The effect of atropine on prevention of vasovagal syncope
Phase 3
Recruiting
- Conditions
- effect of atropine on prevention of vasovagal syncope.
- Registration Number
- IRCT20191231045957N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patient's informed consent to participate in the study
ASAII,III
Female or male aged 15 to 60 years
Exclusion Criteria
People's unwillingness to participate in the study
History of heart disease
History of hypertension medications such as propranolol
History of cigarette alcohol abuse and any drug abuse
History of neurological disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Atropine. Timepoint: Before the intervention, 15 minutes after the intervention and one hour after the intervention. Method of measurement: Milligram and questionnaire.
- Secondary Outcome Measures
Name Time Method